This Article Full Text (OnlineFirst PDF) All Versions of this Article: 0885066608320928v1 0885066608320928v2 23/5/303    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Rady, M. Y. Articles by McGregor, J. Search for Related Content PubMed PubMed Citation Articles by Rady, M. Y. Articles by McGregor, J. Pubmed/NCBI databases Medline Plus Health Information End of Life Issues Social Bookmarking                         What's this?

Organ Procurement After Cardiocirculatory Death: A Critical Analysis

¹ Professor of Medicine, Mayo Clinic College of Medicine
² Physical Medicine and Rehabilitation
³ Biomedical Ethics and Medical Humanities Program

^* To whom correspondence should be addressed. E-mail: rady.mohamed{at}mayo.edu.

	Abstract

To shorten the transplantation waiting time in the United States, federal regulations have been introduced requiring hospitals to develop policies for organ donation after cardiac (or circulatory) death (DCD). The practice of DCD is invoked based on the validity of the University of Pittsburgh Medical Center (UPMC) protocol and relies on the accuracy of the University of Wisconsin (UW) evaluation tool to appropriately identify organ donors. There is little evidence to support the position that the criteria for organ procurement adopted from the UPMC protocol complies with the dead donor rule. A high false-positive rate of the UW evaluation tool can expose many dying patients to unnecessary perimortem interventions because of donation failure. The medications and/or interventions for the sole purpose of maintaining organ viability can have unintended negative consequences on the timing and quality of end-of-life care offered to organ donors. It is essential to address and manage the evolving conflict between optimal end-of-life care and the necessary sacrifices for the procurement of transplantable organs from the terminally ill. The recipients of marginal organs recovered from DCD can also suffer higher mortality and morbidity than recipients of other types of donated organs. Finally, transparent disclosure to the public of the risks involved to both organ donors and recipients may contribute to open societal debate on the ethical acceptability of DCD.

First published on July 22, 2008, doi:10.1177/0885066608320928

Journal of Intensive Care Medicine 2008;23:303.

A more recent version of this article appeared on September 1, 2008
This version was published on July 27, 2008


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?